These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27846390)

  • 21. miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma.
    Su SG; Yang M; Zhang MF; Peng QZ; Li MY; Liu LP; Bao SY
    Int J Biochem Cell Biol; 2017 Oct; 91(Pt A):53-59. PubMed ID: 28867541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.
    Liao P; Zeng SX; Zhou X; Chen T; Zhou F; Cao B; Jung JH; Del Sal G; Luo S; Lu H
    Mol Cell; 2017 Dec; 68(6):1134-1146.e6. PubMed ID: 29225033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Exportin-5 Overrides the Inhibitory Effect of miRNAs Regulation Control and Stabilize Proteins via Posttranslation Modifications in Prostate Cancer.
    Höti N; Yang S; Aiyetan P; Kumar B; Hu Y; Clark D; Eroglu AU; Shah P; Johnson T; Chowdery WH; Zhang H; Rodriguez R
    Neoplasia; 2017 Oct; 19(10):817-829. PubMed ID: 28881308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
    Meng F; Henson R; Wehbe-Janek H; Ghoshal K; Jacob ST; Patel T
    Gastroenterology; 2007 Aug; 133(2):647-58. PubMed ID: 17681183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
    Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
    Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
    Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
    Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
    Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
    Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
    Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNFα reduces eNOS activity in endothelial cells through serine 116 phosphorylation and Pin1 binding: Confirmation of a direct, inhibitory interaction of Pin1 with eNOS.
    Kennard S; Ruan L; Buffett RJ; Fulton D; Venema RC
    Vascul Pharmacol; 2016 Jun; 81():61-8. PubMed ID: 27073025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.
    Kim G; Kim JY; Choi HS
    Biol Pharm Bull; 2015; 38(7):975-9. PubMed ID: 26133706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIN1 in hepatocellular carcinoma is associated with TP53 gene status.
    Bae JS; Noh SJ; Kim KM; Jang KY; Park HS; Chung MJ; Park BH; Moon WS
    Oncol Rep; 2016 Oct; 36(4):2405-11. PubMed ID: 27499097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
    Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).
    Shi X; Teng F
    Mol Cell Biochem; 2015 Oct; 408(1-2):283-93. PubMed ID: 26160280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus x protein and pin1 in liver cancer: "les liaisons dangereuses".
    Avila MA; Lu KP
    Gastroenterology; 2007 Mar; 132(3):1180-3. PubMed ID: 17383439
    [No Abstract]   [Full Text] [Related]  

  • 38. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
    Petrelli A; Perra A; Schernhuber K; Cargnelutti M; Salvi A; Migliore C; Ghiso E; Benetti A; Barlati S; Ledda-Columbano GM; Portolani N; De Petro G; Columbano A; Giordano S
    Oncogene; 2012 Oct; 31(42):4517-26. PubMed ID: 22249248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
    Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.